Evidence map›Paper›PMID 26015805›Full record

ReviewEcancermedicalscience2015

The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study.

Ajay Aggarwal, Karla Unger-Saldaña, Grant Lewison, Richard Sullivan

Open access · goldAbstract readReview
In one paragraph

Review in Ecancermedicalscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cancer drug development: The missing links.Experimental biology and medicine (Maywood, N.J.) · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ajay AggarwalInstitute of Cancer Policy, Kings College London, Guys Campus, Department of Research Oncology, Bermondsey Wing, London, SE1 9RT, UK ; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK.
Karla Unger-SaldañaMexican National Cancer Institute (INCan), 14080 México, D.F.
Grant LewisonInstitute of Cancer Policy, Kings College London, Guys Campus, Department of Research Oncology, Bermondsey Wing, London, SE1 9RT, UK.
Richard SullivanInstitute of Cancer Policy, Kings College London, Guys Campus, Department of Research Oncology, Bermondsey Wing, London, SE1 9RT, UK ; International Prevention Research Institute (iPRI), Lyon 69006, France.
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mexico is undergoing rapid population ageing as a result of its epidemiological transition. This study explores the interface between this rapid population ageing and the burden of cancer. The number of new cancer cases is expected to increase by nearly 75% by 2030 (107,000 additional cases per annum), with 60% of cases in the elderly (aged ≥ 65). A review of the literature was supplemented by a bibliometric analysis of Mexico's cancer research output. Cancer incidence projections for selected sites were estimated with Globocan software. Data were obtained from recent national census, surveys, and cancer death registrations. The elderly, especially women and those living in rural areas, face high levels of poverty, have low rates of educational attainment, and many are not covered by health insurance schemes. Out of pocket payments and private health care usage remain high, despite the implementation of Seguro Popular that was designed to achieve financial protection for the lowest income groups. A number of cancers that predominate in elderly persons are not covered by the scheme and individuals face catastrophic expenditure in seeking treatment. There is limited research output in those cancer sites that have a high burden in the elderly Mexican population, especially research that focuses on outcomes. The elderly population in Mexico is vulnerable to the effects of the rising cancer burden and faces challenges in accessing high quality cancer care. Based on our evidence, we recommend that geriatric oncology should be an urgent public policy priority for Mexico.

Indexed as

ageingcancer burdendemographic transitiongeriatric oncologylow middle-income country

Identifiers

PMID26015805
PMCPMC4435755
OpenAlexW384790660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.